Prof. Dr. Ruben K. Dagda is an Associate Professor at the Department of Pharmacology, University of Nevada Medical School, USA. He obtained his B.S. in Microbiology and M.S. in Biology from the University of Texas at El Paso in 1998 and 2001, respectively, and his Ph.D. in Pharmacology from the University of Iowa in 2006. He received his postdoctoral training at the University of Pittsburgh School of Medicine.
He is currently investigating the molecular mechanisms that lead to mitochondrial dysfunction and oxidative stress in cell culture, tissue, and animal models of Parkinson’s disease. His goal is to develop novel small molecular drugs that can reverse neurodegeneration and elevate mitochondrial function in age-related neurodegenerative diseases.